1 |
Cancer |
16,409 |
 |
2 |
Chemotherapy |
6,058 |
 |
3 |
Metastasis |
5,248 |
 |
4 |
Brain tumor |
4,997 |
 |
5 |
Oncology |
4,749 |
 |
6 |
Palliative care |
4,016 |
 |
7 |
Carcinogen |
3,581 |
 |
8 |
Tumor |
3,428 |
 |
9 |
Radiation therapy |
3,388 |
 |
10 |
Neoplasm |
3,256 |
 |
11 |
Bloating |
2,980 |
 |
12 |
Dysplasia |
2,588 |
 |
13 |
Health effects of tobacco |
2,473 |
 |
14 |
Mammography |
2,228 |
 |
15 |
Malignancy |
2,218 |
 |
16 |
Dermoid cyst |
2,186 |
 |
17 |
Benign tumor |
1,931 |
 |
18 |
Neuroblastoma |
1,780 |
 |
19 |
P53 |
1,777 |
 |
20 |
B-cell chronic lymphocytic leukemia |
1,688 |
 |
21 |
Pancreaticoduodenectomy |
1,664 |
 |
22 |
Hematopoietic stem cell transplantation |
1,586 |
 |
23 |
Burkitt's lymphoma |
1,467 |
 |
24 |
Adenoma |
1,450 |
 |
25 |
Ewing's sarcoma |
1,415 |
 |
26 |
Oncogene |
1,382 |
 |
27 |
Port (medical) |
1,289 |
 |
28 |
Hydatidiform mole |
1,286 |
 |
29 |
Thyroid cancer |
1,272 |
 |
30 |
Paraneoplastic syndrome |
1,242 |
 |
31 |
Liver cancer |
1,146 |
 |
32 |
Alpha-fetoprotein |
1,049 |
 |
33 |
Eye neoplasm |
964 |
 |
34 |
Wilms' tumor |
961 |
 |
35 |
Benignity |
913 |
 |
36 |
Neuroendocrine tumor |
910 |
 |
37 |
Tumor marker |
804 |
 |
38 |
Fibroma |
736 |
 |
39 |
Germ cell tumor |
683 |
 |
40 |
Metaplasia |
682 |
 |
41 |
Tumor suppressor gene |
659 |
 |
42 |
Bcl-2 |
651 |
 |
43 |
Colorectal polyp |
636 |
 |
44 |
Dysplastic nevus |
635 |
 |
45 |
Tumor lysis syndrome |
599 |
 |
46 |
Carcinogenesis |
579 |
 |
47 |
Medulloblastoma |
567 |
 |
48 |
Anaplasia |
563 |
 |
49 |
Intraperitoneal injection |
558 |
 |
50 |
Rhabdomyosarcoma |
555 |
 |
51 |
Phosphoinositide 3-kinase |
526 |
 |
52 |
Fetus in fetu |
507 |
 |
53 |
Peutz–Jeghers syndrome |
501 |
 |
54 |
Sentinel lymph node |
492 |
 |
55 |
Papillary thyroid cancer |
469 |
 |
56 |
Breast self-examination |
442 |
 |
57 |
Alcohol and cancer |
434 |
 |
58 |
Performance status |
429 |
 |
59 |
Cancer stem cell |
407 |
 |
60 |
Superior vena cava syndrome |
394 |
 |
61 |
Thyroid neoplasm |
392 |
 |
62 |
Beta-catenin |
384 |
 |
63 |
Personalized medicine |
383 |
 |
64 |
Myoma |
357 |
 |
65 |
Grading (tumors) |
355 |
 |
66 |
Spinal cord compression |
329 |
 |
67 |
Risks and benefits of sun exposure |
327 |
 |
68 |
Drug resistance |
320 |
 |
69 |
Oncovirus |
320 |
 |
70 |
Gestational trophoblastic disease |
319 |
 |
71 |
Febrile neutropenia |
319 |
 |
72 |
Bone marrow suppression |
315 |
 |
73 |
PET-CT |
306 |
 |
74 |
Adrenal tumor |
305 |
 |
75 |
Glomus tumor |
301 |
 |
76 |
Genotoxicity |
300 |
 |
77 |
Adjuvant cancer therapy |
299 |
 |
78 |
Mediastinal tumor |
291 |
 |
79 |
Desmoplastic small round cell tumor |
285 |
 |
80 |
Sulforaphane |
282 |
 |
81 |
Megestrol |
274 |
 |
82 |
Adeno-associated virus |
260 |
 |
83 |
Medullary thyroid cancer |
251 |
 |
84 |
Histone deacetylase inhibitor |
247 |
 |
85 |
Metastatic breast cancer |
245 |
 |
86 |
Radiation burn |
242 |
 |
87 |
Breslow's depth |
239 |
 |
88 |
Liver tumor |
237 |
 |
89 |
Oncogenesis |
233 |
 |
90 |
Targeted therapy |
228 |
 |
91 |
Pilocytic astrocytoma |
218 |
 |
92 |
Neoadjuvant therapy |
217 |
 |
93 |
Follicular thyroid cancer |
213 |
 |
94 |
Meigs syndrome |
212 |
 |
95 |
Mdm2 |
211 |
 |
96 |
Surgical oncology |
209 |
 |
97 |
Epithelial-mesenchymal transition |
206 |
 |
98 |
Radiosurgery |
205 |
 |
99 |
Dermatofibrosarcoma protuberans |
197 |
 |
100 |
Thyroid adenoma |
196 |
 |
101 |
Cancer vaccine |
185 |
 |
102 |
Atypia |
185 |
 |
103 |
Brainstem glioma |
183 |
 |
104 |
BRCA mutation |
183 |
 |
105 |
Desmoplasia |
182 |
 |
106 |
Primitive neuroectodermal tumor |
177 |
 |
107 |
B symptoms |
176 |
 |
108 |
3,3'-Diindolylmethane |
173 |
 |
109 |
History of cancer chemotherapy |
170 |
 |
110 |
Warburg effect |
167 |
 |
111 |
Atrial myxoma |
164 |
 |
112 |
Oncolytic virus |
161 |
 |
113 |
Experimental cancer treatment |
159 |
 |
114 |
Brain metastasis |
157 |
 |
115 |
Sister Mary Joseph nodule |
155 |
 |
116 |
Anaplastic thyroid cancer |
153 |
 |
117 |
Cancer survivor |
148 |
 |
118 |
Radiation oncologist |
147 |
 |
119 |
Parathyroid hormone-related protein |
145 |
 |
120 |
Microsatellite instability |
144 |
 |
121 |
HPV-positive oropharyngeal cancer |
142 |
 |
122 |
Cancer bacteria |
140 |
 |
123 |
Warburg hypothesis |
133 |
 |
124 |
Hepatoblastoma |
132 |
 |
125 |
Homeobox protein NANOG |
131 |
 |
126 |
Salivary gland cancer |
129 |
 |
127 |
List of oncology-related terms |
126 |
 |
128 |
Oncotype DX |
126 |
 |
129 |
Spontaneous remission |
125 |
 |
130 |
Lymphadenectomy |
124 |
 |
131 |
STAT protein |
122 |
 |
132 |
Inferior vena cava syndrome |
120 |
 |
133 |
DNA adduct |
119 |
 |
134 |
Knudson hypothesis |
116 |
 |
135 |
Response Evaluation Criteria in Solid Tumors |
116 |
 |
136 |
SH-SY5Y |
116 |
 |
137 |
Post-chemotherapy cognitive impairment |
116 |
 |
138 |
Image-guided radiation therapy |
116 |
 |
139 |
PC3 |
114 |
 |
140 |
Dukes classification |
113 |
 |
141 |
Survivin |
106 |
 |
142 |
Carcinosis |
106 |
 |
143 |
Leukemia inhibitory factor |
103 |
 |
144 |
Granular cell tumor |
100 |
 |
145 |
Chemotherapy-induced acral erythema |
100 |
 |
146 |
Mass effect (medicine) |
99 |
 |
147 |
Hormonal therapy (oncology) |
99 |
 |
148 |
Incidentaloma |
96 |
 |
149 |
Virtual Karyotype |
95 |
 |
150 |
Cancer immunology |
93 |
 |
151 |
Management of cancer |
92 |
 |
152 |
European Prospective Investigation into Cancer and Nutrition |
91 |
 |
153 |
Pel-Ebstein fever |
91 |
 |
154 |
Juvenile myelomonocytic leukemia |
90 |
 |
155 |
Dysgerminoma |
88 |
 |
156 |
Malignant transformation |
87 |
 |
157 |
Diet and cancer |
86 |
 |
158 |
Tumor antigen |
85 |
 |
159 |
Circulating tumor cell |
85 |
 |
160 |
Debulking |
84 |
 |
161 |
War on Cancer |
84 |
 |
162 |
Surface epithelial-stromal tumor |
82 |
 |
163 |
Oncology nursing |
82 |
 |
164 |
Geron Corporation |
81 |
 |
165 |
Hepatectomy |
81 |
 |
166 |
Small blue round cell tumour |
77 |
 |
167 |
LNCaP |
76 |
 |
168 |
Linear no-threshold model |
73 |
 |
169 |
Struma ovarii |
73 |
 |
170 |
Transmissible cancer |
73 |
 |
171 |
National Comprehensive Cancer Network |
71 |
 |
172 |
Juvenile polyposis syndrome |
70 |
 |
173 |
Retroperitoneal lymph node dissection |
69 |
 |
174 |
Glutaminolysis |
69 |
 |
175 |
Vaginal intraepithelial neoplasia |
68 |
 |
176 |
Epidemiology of cancer |
67 |
 |
177 |
Breast cancer chemotherapy |
64 |
 |
178 |
CD137 |
62 |
 |
179 |
Pelvic tumor |
61 |
 |
180 |
International Prognostic Index |
60 |
 |
181 |
Double minute |
59 |
 |
182 |
Pleomorphic xanthoastrocytoma |
59 |
 |
183 |
Lymphogram |
58 |
 |
184 |
Cronkhite–Canada syndrome |
56 |
 |
185 |
Lahey Clinic |
55 |
 |
186 |
DU145 |
55 |
 |
187 |
Length time bias |
54 |
 |
188 |
Papillary fibroelastoma |
54 |
 |
189 |
HT1080 |
54 |
 |
190 |
Chlorotoxin |
52 |
 |
191 |
Cancer patient |
51 |
 |
192 |
Gynecologic oncology |
51 |
 |
193 |
Hazardous drugs |
51 |
 |
194 |
Pagetoid |
50 |
 |
195 |
American Society of Clinical Oncology |
49 |
 |
196 |
Histiocytic sarcoma |
49 |
 |
197 |
Tumor hypoxia |
48 |
 |
198 |
Enhanced permeability and retention effect |
48 |
 |
199 |
Lymphangitis carcinomatosa |
48 |
 |
200 |
Solitary fibrous tumor |
47 |
 |
201 |
Alcohol and breast cancer |
45 |
 |
202 |
Fibrillary astrocytoma |
45 |
 |
203 |
Amsterdam criteria |
44 |
 |
204 |
Secreted frizzled-related protein 1 |
44 |
 |
205 |
Cancer cluster |
43 |
 |
206 |
Treatment planning |
43 |
 |
207 |
MDV3100 |
43 |
 |
208 |
Glandular and epithelial neoplasm |
42 |
 |
209 |
Cancer registry |
40 |
 |
210 |
Delaney clause |
39 |
 |
211 |
Somatic evolution in cancer |
39 |
 |
212 |
Radiosensitivity |
38 |
 |
213 |
Desmoplastic fibroma |
38 |
 |
214 |
Peritoneal mesothelioma |
38 |
 |
215 |
P73 |
37 |
 |
216 |
Aflatoxicosis and cancer effects of Aflatoxin |
37 |
 |
217 |
Cancer screening |
37 |
 |
218 |
Dysplastic nevus syndrome |
36 |
 |
219 |
Laparoscopic radical prostatectomy |
36 |
 |
220 |
American Association for Cancer Research |
34 |
 |
221 |
Radiological Physics Center |
34 |
 |
222 |
Fertility preservation |
34 |
 |
223 |
Anticarcinogen |
33 |
 |
224 |
Micrometastasis |
33 |
 |
225 |
Gonadoblastoma |
33 |
 |
226 |
Cock's peculiar tumour |
33 |
 |
227 |
CaBIG |
32 |
 |
228 |
Cancell |
32 |
 |
229 |
Kidney tumour |
32 |
 |
230 |
Embryonal rhabdomyosarcoma |
32 |
 |
231 |
Virotherapy |
31 |
 |
232 |
Fibroepithelial neoplasms |
31 |
 |
233 |
Psycho-oncology |
31 |
 |
234 |
Orthopedic oncologist |
30 |
 |
235 |
Renal medullary carcinoma |
30 |
 |
236 |
Epithelial dysplasia |
30 |
 |
237 |
William Donald Kelley |
29 |
 |
238 |
Patient trade-off |
29 |
 |
239 |
ARF tumor suppressor |
29 |
 |
240 |
Myeloma protein |
27 |
 |
241 |
Cancer syndromes |
27 |
 |
242 |
Co-carcinogen |
27 |
 |
243 |
Magnetic hyperthermia |
27 |
 |
244 |
Qadir's test |
27 |
 |
245 |
Trophoblastic neoplasm |
26 |
 |
246 |
Pancreatoblastoma |
26 |
 |
247 |
Marc Lacroix |
26 |
 |
248 |
Bolus (radiation therapy) |
26 |
 |
249 |
Endometrial intraepithelial neoplasia |
25 |
 |
250 |
Luteoma |
25 |
 |
251 |
ALVAC-CEA vaccine |
25 |
 |
252 |
Fibrous tissue neoplasm |
25 |
 |
253 |
Intraocular lymphoma |
24 |
 |
254 |
Oncofertility Consortium |
24 |
 |
255 |
Complex and mixed tumor |
24 |
 |
256 |
Acute biphenotypic leukaemia |
24 |
 |
257 |
Metastatic liver disease |
24 |
 |
258 |
Multilobular tumour of bone |
24 |
 |
259 |
4-Nitroquinoline 1-oxide |
23 |
 |
260 |
Children's Oncology Group |
23 |
 |
261 |
Massimo Mazzucco |
23 |
 |
262 |
Angel Ortiz |
23 |
 |
263 |
Aberrant crypt foci |
23 |
 |
264 |
Imaging agent |
22 |
 |
265 |
Pediatric Cancer Research Foundation |
22 |
 |
266 |
Eastern Cooperative Oncology Group |
22 |
 |
267 |
Medulloepithelioma |
22 |
 |
268 |
Antibody-drug conjugate |
22 |
 |
269 |
Intergroup Rhabdomyosarcoma Study Group |
21 |
 |
270 |
Photothermal Therapy |
21 |
 |
271 |
Cancer previvor |
21 |
 |
272 |
Tumor infiltrating lymphocyte |
21 |
 |
273 |
1953 Fitzgerald Report |
21 |
 |
274 |
Ganglioneuroblastoma |
21 |
 |
275 |
Serous tumour |
20 |
 |
276 |
Leucoerythroblastic |
20 |
 |
277 |
Janus Experiments |
20 |
 |
278 |
Biochemical recurrence |
20 |
 |
279 |
Bioluminescent activated destruction |
20 |
 |
280 |
Vattikuti Urology Institute |
20 |
 |
281 |
Help Conquer Cancer |
20 |
 |
282 |
New Century Infusion Solutions, Inc. |
20 |
 |
283 |
Community Oncology Alliance |
20 |
 |
284 |
Tumor M2-PK |
19 |
 |
285 |
Common Toxicity Criteria |
19 |
 |
286 |
Cancer and Leukemia Group B |
19 |
 |
287 |
CIT Program Tumor Identity Cards |
19 |
 |
288 |
Polysaccharide Peptide |
18 |
 |
289 |
CaGrid |
18 |
 |
290 |
Adrenocortical adenoma |
18 |
 |
291 |
Electrochemotherapy |
18 |
 |
292 |
Hormone receptor positive tumor |
18 |
 |
293 |
Forequarter amputation |
18 |
 |
294 |
Subependymoma |
18 |
 |
295 |
Mesenchymal-epithelial transition |
18 |
 |
296 |
Midwest Proton Radiotherapy Institute |
18 |
 |
297 |
Neoplastic meningitis |
17 |
 |
298 |
Veterinary oncology |
17 |
 |
299 |
Pancreatic masses |
17 |
 |
300 |
TARGIT |
17 |
 |
301 |
Hong Kong Cancer Fund |
17 |
 |
302 |
Bionovo |
16 |
 |
303 |
Glomangiosarcoma |
16 |
 |
304 |
Tower Cancer Research Foundation |
16 |
 |
305 |
Georg F. Weber |
15 |
 |
306 |
Benign proliferative breast disease |
15 |
 |
307 |
Automated tissue image analysis |
15 |
 |
308 |
Gray zone lymphoma |
15 |
 |
309 |
Fractional kill |
15 |
 |
310 |
Targetoid |
14 |
 |
311 |
CBLB502 |
14 |
 |
312 |
Adnexal and skin appendage neoplasms |
14 |
 |
313 |
Southwest Oncology Group |
13 |
 |
314 |
Tumor metabolome |
13 |
 |
315 |
Ovacome – The Ovarian Cancer Support Network |
13 |
 |
316 |
Roxana Moslehi |
13 |
 |
317 |
Polyembryoma |
13 |
 |
318 |
Cancer Association of Botswana |
13 |
 |
319 |
Oncomir |
13 |
 |
320 |
Ralph W. Moss (science writer) |
13 |
 |
321 |
Anticancer plants |
13 |
 |
322 |
Hedyotis diffusa |
13 |
 |
323 |
Ghost cell |
12 |
 |
324 |
Distress In Cancer Caregiving |
12 |
 |
325 |
Znf202 |
11 |
 |
326 |
Contact normalization |
11 |
 |
327 |
Help Fight Childhood Cancer |
11 |
 |
328 |
ISREC |
10 |
 |
329 |
Methylation specific oligonucleotide microarray |
10 |
 |
330 |
Bone-seeking radioisotope |
10 |
 |
331 |
Genetics of cancer |
10 |
 |
332 |
Robert Goldman (inventor) |
10 |
 |
333 |
European Society for Medical Oncology |
9 |
 |
334 |
Occupational Cancer Convention, 1974 |
9 |
 |
335 |
Dose profile |
9 |
 |
336 |
Growth inhibition |
9 |
 |
337 |
Integrated Single Specialty Provider |
9 |
 |
338 |
Instruments used in oncology |
9 |
 |
339 |
Bogart Pediatric Cancer Research Program |
9 |
 |
340 |
Endocrine paraneoplastic syndrome |
9 |
 |
341 |
Paolo Boffetta |
9 |
 |
342 |
Flexner-Wintersteiner rosette |
9 |
 |
343 |
Cancer guided imagery |
8 |
 |
344 |
Ectomesenchymoma |
8 |
 |
345 |
M1G |
8 |
 |
346 |
International Society for Biological Therapy of Cancer |
8 |
 |
347 |
Geriatric oncology |
8 |
 |
348 |
EuroPharm Forum |
8 |
 |
349 |
Anethole dithione |
8 |
 |
350 |
Carlo La Vecchia |
8 |
 |
351 |
Diktyoma |
8 |
 |
352 |
Pleural fibroma |
8 |
 |
353 |
Action study |
7 |
 |
354 |
Komen Brinker Award for Scientific Distinction |
7 |
 |
355 |
Cancer Act 1939 |
7 |
 |
356 |
Neurooncology |
7 |
 |
357 |
EBC-46 |
7 |
 |
358 |
BEZ235 |
7 |
 |
359 |
Armitage–Doll multistage model of carcinogenesis |
6 |
 |
360 |
Incidentalome |
6 |
 |
361 |
Continuous hyperthermic peritoneal perfusion |
6 |
 |
362 |
Hypoxia activated prodrugs |
6 |
 |
363 |
LIVERight |
6 |
 |
364 |
European Society of Gynaecological Oncology |
6 |
 |
365 |
Oncology benefit management |
6 |
 |
366 |
New Approaches to Cancer |
less than 5 views |
|
367 |
Percutaneous hepatic perfusion |
less than 5 views |
|
368 |
American College of Surgeons Oncology Group |
less than 5 views |
|
369 |
Breast duct endoscopy |
less than 5 views |
|
370 |
Autologous tumor cell |
less than 5 views |
|
371 |
Physician Data Query |
less than 5 views |
|
372 |
ADH-1 |
less than 5 views |
|
373 |
MALOVA |
less than 5 views |
|
374 |
The Cancer Center at the University of Minnesota |
less than 5 views |
|
375 |
Oncology-related terms |
less than 5 views |
|
376 |
Vestibular tumor |
less than 5 views |
|
377 |
Learning problems in childhood cancer |
less than 5 views |
|
378 |
Polyposis registries |
less than 5 views |
|
379 |
Women with ovarian cancer |
less than 5 views |
|
380 |
Delcath Systems, Inc. |
less than 5 views |
|
381 |
Agent study |
less than 5 views |
|
382 |
Cancer types |
less than 5 views |
|
383 |
Anterior urethral cancer |
less than 5 views |
|
384 |
Malignant ectomesenchymoma |
less than 5 views |
|
385 |
AYA Cancer |
less than 5 views |
|
386 |
Oncoantigen |
less than 5 views |
|
387 |
Biomed 101 |
less than 5 views |
|
388 |
Cancer immunoprevention |
less than 5 views |
|
389 |
AllergoOncology |
less than 5 views |
|
390 |
Australasian College of Physical Scientists and Engineers in Medicine |
less than 5 views |
|
391 |
Semicarbazide-cadmium therapy |
less than 5 views |
|
392 |
21st Century Cancer Access to Life-Saving Early detection, Research and Treatment (ALERT) Act |
less than 5 views |
|
393 |
Osteomimicry |
less than 5 views |
|
394 |
Non islet hypoglycemic cell tumor |
less than 5 views |
|
395 |
Replication error phenotype |
less than 5 views |
|
396 |
Philippe Autier |
less than 5 views |
|
397 |
Kaiso (gene) |
less than 5 views |
|
398 |
Arbiskov cell |
less than 5 views |
|
399 |
Glycoprotein 100 |
less than 5 views |
|